Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Raloxifene/Cholecalciferol FDC vs Co-administration in Healthy Males
NCT02762643Phase 1Completed
- Sponsor
- Alvogen
- Start
- May 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Raloxifene + cholecalciferol in osteoporosis (2 arms), sponsored by Alvogen. Primary endpoints: Area under the plasma concentration versus time curve and Peak Plasma Concentration. Started May 2016; status: completed.
02
Drugs
Raloxifene + cholecalciferol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02762643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02762643.